Eight-Year Data for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Continue to Demonstrate Longest Survival Benefit vs. Sunitinib Reported in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
Patients with previously untreated advanced or metastatic renal cell carcinoma treated with Opdivo plus Yervoy experienced a 28% reduction in the risk of death vs.... Read more.
Cushman & Wakefield to Release Fourth Quarter and Full Year 2023 Earnings on February 20
CHICAGO–(BUSINESS WIRE)–#cre–Cushman & Wakefield (NYSE: CWK) will release its fourth quarter and full year 2023 financial results after the... Read more.
Principal® CEO Dan Houston to Speak at 2024 Bank of America Financial Services Conference
DES MOINES, Iowa–(BUSINESS WIRE)–Principal Financial Group® (Nasdaq: PFG) announced today that Dan Houston, chairman, president, and chief executive... Read more.
Opdivo® (nivolumab) in Combination with CABOMETYX® (cabozantinib) Demonstrates Long-Term Survival Benefits After Four Years of Follow-Up in the CheckMate -9ER Trial in First-Line Advanced Renal Cell Carcinoma
Opdivo in combination with CABOMETYX reduced the risk of death by 23% in the first-line treatment of advanced renal cell carcinoma vs. sunitinib Four-year results... Read more.
Independent Bank Group, Inc. Reports Fourth Quarter Financial Results and Declares Quarterly Dividend
MCKINNEY, Texas–(BUSINESS WIRE)–Independent Bank Group, Inc. (NASDAQ: IBTX) today announced net income of $14.9 million, or $0.36 per diluted share,... Read more.
Chatham Lodging Trust Announces 2023 Distribution Characterization
WEST PALM BEACH, Fla.–(BUSINESS WIRE)–Chatham Lodging Trust (NYSE: CLDT), a lodging real estate investment trust (REIT) that invests in upscale extended-stay... Read more.
Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Not intended for UK-, US- or Canada-based media Abstracts to be presented at the 2024 American Society of Clinical Oncology’s annual Genitourinary Cancers Symposium... Read more.
Excelerate Energy Announces Fourth Quarter and Full Year 2023 Earnings Conference Call Date
THE WOODLANDS, Texas–(BUSINESS WIRE)–Excelerate Energy, Inc. (NYSE: EE) (the “Company” or “Excelerate”) will release its fourth quarter and full... Read more.
Baron & Budd Environmental Practice Named to Law360’s 2023 Practice Group of the Year
DALLAS–(BUSINESS WIRE)–Today, the nationally recognized law firm Baron & Budd is pleased to announce that the firm’s Environmental Litigation Group... Read more.
Three Hicks Thomas Partners Named to Lawdragon’s 500 Leading Lawyers in America
Partners recognized for excellence in business litigation HOUSTON–(BUSINESS WIRE)–Hicks Thomas LLP partners John B. Thomas, Courtney E. Ervin and Robin... Read more.